AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionAlphaStar Capital Management, LLC
Latest Disclosed Ownership19,244 shares
Latest Disclosed Value $ 4,185,441
AlphaStar Capital Management, LLC reports 23.81% decrease in ownership of 4AB / AbbVie Inc.

On April 15, 2026 - AlphaStar Capital Management, LLC filed a 13F-HR form disclosing ownership of 19,244 shares of AbbVie Inc. (BG:4AB) valued at $4,185,441 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 25,257 shares of AbbVie Inc.. This represents a change in shares of -23.81% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-15 2026-03-31 13F ABBVIE COM 00287Y109 19,244 -6,013 -23.81 4,185 -27.47 0.3086
2026-02-02 2025-12-31 13F ABBVIE COM 00287Y109 25,257 1,033 4.26 5,771 2.89 0.4235
2025-11-13 2025-09-30 13F ABBVIE COM 00287Y109 24,224 1,182 5.13 5,609 31.15 0.4834
2025-08-04 2025-06-30 13F ABBVIE COM 00287Y109 23,042 -1,412 -5.77 4,277 -16.53 0.3006
2025-04-30 2025-03-31 13F ABBVIE COM 00287Y109 24,454 -8,579 -25.97 5,124 -12.71 0.5156
2025-01-28 2024-12-31 13F ABBVIE COM 00287Y109 33,033 3,607 12.26 5,870 1.00 0.6136
2024-11-12 2024-09-30 13F ABBVIE COM 00287Y109 29,426 1,849 6.70 5,811 22.88 0.4608
2024-07-26 2024-06-30 13F ABBVIE COM 00287Y109 27,577 1,242 4.72 4,730 -1.38 0.4367
2024-05-08 2024-03-31 13F ABBVIE COM 00287Y109 26,335 2,339 9.75 4,796 28.97 0.4920
2024-02-07 2023-12-31 13F ABBVIE COM 00287Y109 23,996 581 2.48 3,719 6.53 0.3395
2023-11-08 2023-09-30 13F ABBVIE COM 00287Y109 23,415 -483 -2.02 3,490 8.42 0.4366
2023-08-03 2023-06-30 13F ABBVIE COM 00287Y109 23,898 73 0.31 3,220 -15.22 0.3633
2023-05-03 2023-03-31 13F ABBVIE COM 00287Y109 23,825 -7,894 -24.89 3,797 -25.93 0.3226
2023-02-08 2022-12-31 13F ABBVIE COM 00287Y109 31,719 8,224 35.00 5,126 62.58 0.5271
2022-10-21 2022-09-30 13F ABBVIE COM 00287Y109 23,495 1,226 5.51 3,153 -7.56 0.3385
2022-07-27 2022-06-30 13F ABBVIE COM 00287Y109 22,269 1,415 6.79 3,411 0.89 0.3152
2022-04-28 2022-03-31 13F ABBVIE COM 00287Y109 20,854 619 3.06 3,381 22.99 0.2729
2022-02-04 2021-12-31 13F ABBVIE COM 00287Y109 20,235 -4,106 -16.87 2,749 4.05 0.2192
2021-11-02 2021-09-30 13F ABBVIE COM 00287Y109 24,341 9,783 67.20 2,642 61.10 0.1800
2021-07-30 2021-06-30 13F AbbVie COM 00287Y109 14,558 1,532 11.76 1,640 16.31 0.2101
2021-05-03 2021-03-31 13F AbbVie COM 00287Y109 13,026 -82 -0.63 1,410 -3.82 0.2190
2021-01-27 2020-12-31 13F AbbVie COM 00287Y109 13,108 5,422 70.54 1,466 123.14 0.2488
2020-10-28 2020-09-30 13F AbbVie COM 00287Y109 7,686 2,416 45.84 657 23.96 0.1314
2020-08-06 2020-06-30 13F ABBVIE COM 00287Y109 5,270 536 11.32 530 39.47 0.1132
2020-05-05 2020-03-31 13F ABBVIE COM 00287Y109 4,734 -25 -0.53 380 -9.74 0.0895
2020-02-11 2019-12-31 13F ABBVIE COM 00287Y109 4,759 513 12.08 421 30.75 0.0914
2019-11-14 2019-09-30 13F ABBVIE COM 00287Y109 4,246 -306 -6.72 322 -2.72 0.0768
2019-08-14 2019-06-30 13F ABBVIE COM 00287Y109 4,552 -93 -2.00 331 -11.50 0.0836
2019-04-25 2019-03-31 13F ABBVIE COM 00287Y109 4,645 207 4.66 374 -8.56 0.1048
2019-02-13 2018-12-31 13F ABBVIE COM 00287Y109 4,438 -25 -0.56 409 -3.08 0.1306
2018-11-13 2018-09-30 13F ABBVIE COM 00287Y109 4,463 -193 -4.15 422 -2.09 0.1241
2018-08-14 2018-06-30 13F ABBVIE COM 00287Y109 4,656 -456 -8.92 431 -10.95 0.1358
2018-05-14 2018-03-31 13F ABBVIE COM 00287Y109 5,112 261 5.38 484 3.20 0.1837
2018-02-12 2017-12-31 13F ABBVIE COM 00287Y109 4,851 4,851 469 0.1210
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.